Gaxos.ai Inc. (NASDAQ: GXAI) has outlined its post-divestiture operating strategy following the sale of its gaming assets, signaling a concentrated focus on expanding its AI applications business through Gaxos Labs and the personalized health and wellness offerings of majority-owned subsidiary RNK Health. The strategic realignment was detailed in a press release, which highlighted first-quarter 2026 revenue growth to approximately $1.81 million, driven primarily by RNK Health and subscriptions to Gaxos Labs applications.
The company's new priorities include scaling revenue-generating platforms, improving customer acquisition efficiency, advancing commercially focused AI products, and maintaining disciplined capital allocation. Gaxos.ai also plans to continue holding its 19.99% ownership interest in America First Defense.AI while providing separate reporting on that investment. Additionally, the company intends to enhance investor communications with additional operating performance metrics as its businesses continue to grow.
Gaxos.ai describes itself as a technology company focused on reshaping how people interact with artificial intelligence across everyday life and high-impact industries. Its portfolio spans defense, health and wellness, entertainment, and productivity, aiming to make advanced technology more practical and accessible. For more details on the announcement, the full press release is available at https://ibn.fm/G9Ld7.
The company's strategic shift comes as it leverages its AI capabilities in growing markets. By divesting gaming assets, Gaxos.ai can allocate resources more efficiently to its core AI and health businesses, which have already demonstrated revenue growth. The emphasis on scalable platforms and customer acquisition efficiency indicates a focus on sustainable growth and profitability.
Investors can find the latest news and updates relating to GXAI in the company’s newsroom at https://ibn.fm/GXAI. This realignment positions Gaxos.ai to capitalize on the increasing demand for AI solutions in health and other sectors, potentially driving further value for shareholders.
